Featured

Pharmaceutical products undergo an extensive journey from lab to patient, traversing various modes of transportation in the supply chain. The last leg of this journey, known as the "last mile," becomes particularly complex in the cold chain. This stage...

Contract Development and Manufacturing Organizations (CDMOs), which pharmaceutical companies increasingly delegate product development and manufacturing, operate in a fragmented market undergoing substantial consolidation. Yet, many CDMOs fail to fully capitalize on pricing projects, risking competitiveness. To thrive, they must...

According to insights, the pharmaceutical CDMO market is projected to grow at a Compound Annual Growth Rate (CAGR) of 7.29% until 2028. This growth could be attributed to the expanding pharmaceutical sector, driven by the increasing usage of analytics...

The US Food and Drug Administration has released a draft guidance on good clinical practices (GCPs) to improve the design and implementation of clinical trials. The goal is to make trials more flexible while maintaining data accuracy and participant...

The Centre for Process Innovation (CPI) plans to establish a new Intracellular Drug Delivery Centre in the UK to develop innovative lipid nanoparticle (LNP) formulations for delivering RNA-based medicines. This partnership, funded by a £10 million grant from Innovate...

A report has been published by international regulators that highlights the outcomes of the discussion they had pertaining to COVID-19 vaccines, as well as the need for and the strategy so as to update the composition based on evidence...

The medicines and healthcare products regulatory agency has gone on to announce that the new global regulatory recognition routes for drugs will be established by making use of approvals from Singapore, Canada, Japan, the US, Australia, Switzerland, and, of...